Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Treatment of multiple sclerosis in children and its challenges.
Information provision for people with multiple sclerosis.
The immunogenetics of multiple sclerosis: A comprehensive review.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Nitric oxide inhibits CXCL12 expression in neuroinflammation.
Benchmarks of meaningful impairment on the MSFC and BICAMS.
Improving Safety and Operational Efficiency in Residential Care Settings With WiFi-Based Localization.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Models for treating depression in specialty medical settings: a narrative review.
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
[An update on the treatment options for multiple sclerosis].
Prediction of antibody persistency from antibody titres to natalizumab.
Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping.
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
Imaging resting state brain function in multiple sclerosis.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Patient Characteristics Associated with Medication Adherence.
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled
Multiple sclerosis: KIR4.1 as an autoantigen in MS-new questions raised.
Multiple sclerosis: Brain volume loss strengthens disease measure.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
The effect of ribavirin on reactive astrogliosis in experimental autoimmune encephalomyelitis.
Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis.

Pages